Quick Answer
Bio Green Med Solution, Inc. reported Diluted EPS of $6.45 per share (loss) for fiscal year 2025.
Bio Green Med Solution, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$6.45 | +98.7% |
| 2024 | -$502.46 | -1778.4% |
| 2023 | -$26.75 | +1.8% |
| 2022 | -$27.24 | -1172.9% |
| 2021 | -$2.14 | +37.4% |
| 2020 | -$3.42 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.31 | +97.0% | -33.7% |
| June 30, 2025 | -$0.98 | +99.4% | — |
| March 31, 2025 | $0.00 | +100.0% | +100.0% |
| September 30, 2024 | -$43.80 | — | +74.6% |
| June 30, 2024 | -$172.18 | -39031.8% | -7485.0% |
| March 31, 2024 | -$2.27 | +67.6% | -415.9% |
| June 30, 2023 | -$0.44 | +4.3% | +93.7% |
| March 31, 2023 | -$7.00 | -1566.7% | -1566.7% |
- Bio Green Med Solution, Inc. showed an increase of +98.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, Bio Green Med Solution, Inc.’s diluted eps has declined by 88.6% (from $3.42 per share (loss) to $6.45 per share (loss)).
- The most recent figure is from Bio Green Med Solution, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: